Author

Tatjana Arsenijevic

Université Libre de BruxellesORCID 0000-0002-7261-5587Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Christelle BouchartiD· 3 shared Julie NaveziD· 3 shared Laurine VersetiD· 3 shared Oier Azurmendi SenariD· 3 shared Ilse RoomaniD· 2 shared Kosta StosiciD· 2 shared Pieter DemetteriD· 2 shared Rémy NicolleiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Christelle BouchartORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Luminal-Basal Stratification of the Native Human Pancreatic Duct is Differentially Represented in Pancreatic Cancers

Jan-Lars Van den Bossche, Melissa Van der Vliet, Ellis Michiels, Oier Azurmendi Senar, Silke Van Lint, Zeynep Madran, Katarina Coolens, Jack Brons, Montserrat Nacher, Tatjana Arsenijevic, Nouredin Messaoudi, Pierre Lefesvre, Christelle Bouchart, Laurine Verset, Julie Navez, , Ilse Rooman

This study identifies spatially distinct cell populations in human pancreatic ducts and shows that ASCP better preserves native cell identities compared to PDAC.

Gut · Jun 4, 2026Peer-reviewedCancer Biology

Glycation Stress-Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Pancreatic Cancer.

Oier Azurmendi Senar, Kosta Stosic, Christelle Bouchart, Julie Navez, Jawad Tarfouss, Rebekah Crake, Laurine Verset, Pieter Demetter, Marjorie Mauduit, Thierry Conroy, Jerome F. Cros, Rémy Nicolle, Manuel Saiselet, Joel Rodrigues Vitória, Vincent Detours, , Jean-Luc Van-Laethem

The paper develops a 16-gene signature (MG-GEM) that predicts survival benefit from adjuvant gemcitabine in resectable pancreatic cancer based on glycation stress, outperforming existing signatures.

bioRxiv · Jul 7, 2025 · PreprintCancer Biology

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy

Christelle Bouchart, Oier Azurmendi Senar, Julie Navez, Laurine Verset, Anaïs Boisson, Matthieu Hein, Kosta Stosic, Eric Quertinmont, Vjola Tafciu, Shulin Zhao, Léo Mas, Nicky D’Haene, Dirk Van Gestel, Luigi Moretti, Ilse Rooman, , Jean‐Luc Van Laethem

This study shows that combining FOLFIRINOX with stereotactic body radiotherapy remodels pancreatic ductal adenocarcinoma, improving stromal and metabolic features and prognosis.

bioRxiv · Apr 30, 2024 · PreprintCancer Biology